Roche agrees HIV therapy dealsOctober 2008
The Roche pharmaceuticals company has entered into four new technology transfers with manufacturers in Bangladesh and three African countries where better access to HIV therapy is needed.
Under the agreement Beximar Pharmaceuticals in Bangladesh and manufacturers in Kenya, Tanzania and Zimbabwe will receive free technical expertise to make generic HIV medicine, based on the processes used by Roche to produce saquinavir.
Roche teams will work at all four factories and from the company’s headquarters in Switzerland to undertake the technology transfers.
William Burns, Roche Pharma’s chief executive, said the company was hoping to ‘strengthen and expand local manufacturing capabilities for HIV medicines in resource-limited countries’.
In addition to the four agreements Roche has expanded the Technology Transfer Initiative with training seminars for companies in developing countries. The emphasis will be on improved manufacturing processes.
Already a member? click here to login